GlassScriptPhysician profile
Daniel K Vaught
NPI 1609282482
$5,211.92
in general payments reported to CMS, 2019-2025
37 companies · $1,132 in 2025
The $1,132 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $768 · 2022: $1,352 · 2023: $755 · 2024: $1,204 · 2025: $1,132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,092.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,092.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,003.46 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $934.04 | 2021-2025 | |
| Novo Nordisk INC | $341.86 | 2021-2025 | Rybelsus, Ozempic |
| Lilly USA, LLC | $332.95 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $328.52 | 2022-2025 | Caplyta |
| Amgen INC. | $260.58 | 2021-2025 | Otezla, Repatha, Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $246.68 | 2022-2025 | |
| Scilex Pharmaceuticals INC. | $125.13 | 2021-2025 | |
| Pfizer INC. | $125.12 | 2021-2025 | |
| Aimmune Therapeutics, INC. | $116.41 | 2024-2025 | Zenpep |
| Novartis Pharmaceuticals Corporation | $116.29 | 2022-2023 | |
| Philips North America LLC | $110.89 | 2021-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.44 | 2021-2024 | Synjardy, Jardiance, Tradjenta |
| Nevro Corp. | $103.93 | 2023-2024 | Senza |
| Otsuka America Pharmaceutical, INC. | $95.84 | 2021-2025 | Rexulti |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Vaught listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.